Free Trial

Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives $13.55 Consensus Price Target from Analysts

Integral Ad Science logo with Business Services background

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) has been given an average rating of "Moderate Buy" by the twelve ratings firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $13.55.

Several equities research analysts have recently weighed in on IAS shares. Barclays upped their target price on Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 13th. Wall Street Zen cut shares of Integral Ad Science from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Baird R W cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Friday, March 28th. Finally, Stifel Nicolaus decreased their target price on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd.

Check Out Our Latest Research Report on IAS

Integral Ad Science Trading Up 2.3%

NASDAQ:IAS traded up $0.18 during mid-day trading on Friday, reaching $8.16. The company's stock had a trading volume of 1,082,181 shares, compared to its average volume of 1,004,072. Integral Ad Science has a twelve month low of $6.26 and a twelve month high of $13.62. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The company's fifty day simple moving average is $7.42 and its two-hundred day simple moving average is $9.29. The stock has a market cap of $1.35 billion, a P/E ratio of 40.80, a P/E/G ratio of 1.06 and a beta of 1.55.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $134.07 million for the quarter, compared to the consensus estimate of $129.20 million. On average, equities analysts predict that Integral Ad Science will post 0.26 EPS for the current year.

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 68,671 shares of the business's stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $7.44, for a total transaction of $510,912.24. Following the sale, the chief executive officer now directly owns 334,051 shares of the company's stock, valued at $2,485,339.44. The trade was a 17.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last quarter, insiders have sold 86,222 shares of company stock valued at $636,252. 2.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Integral Ad Science

Several institutional investors and hedge funds have recently bought and sold shares of the business. Jennison Associates LLC grew its stake in shares of Integral Ad Science by 3.3% in the 4th quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock valued at $663,000 after buying an additional 2,046 shares in the last quarter. Stoneridge Investment Partners LLC boosted its position in shares of Integral Ad Science by 139.7% in the fourth quarter. Stoneridge Investment Partners LLC now owns 27,808 shares of the company's stock valued at $290,000 after acquiring an additional 16,208 shares during the period. Rice Hall James & Associates LLC grew its position in Integral Ad Science by 89.2% in the 4th quarter. Rice Hall James & Associates LLC now owns 314,129 shares of the company's stock worth $3,280,000 after purchasing an additional 148,082 shares during the last quarter. Handelsbanken Fonder AB bought a new position in Integral Ad Science during the fourth quarter valued at about $162,000. Finally, Bank of New York Mellon Corp lifted its position in Integral Ad Science by 13.1% in the fourth quarter. Bank of New York Mellon Corp now owns 251,091 shares of the company's stock worth $2,621,000 after purchasing an additional 29,145 shares during the period. Hedge funds and other institutional investors own 95.78% of the company's stock.

About Integral Ad Science

(Get Free Report

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Recommended Stories

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Should You Invest $1,000 in Integral Ad Science Right Now?

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines